Cargando…

Photocatalytic degradation of Metronidazole with illuminated TiO(2) nanoparticles

Metronidazole (MNZ) is a brand of nitroimidazole antibiotic, which is generally used in clinical applications and extensively used for the treatment of infectious diseases caused by anaerobic bacteria and protozoans. The aim of this investigation was to degrade MNZ with illuminated TiO(2) nanopartic...

Descripción completa

Detalles Bibliográficos
Autores principales: Farzadkia, Mahdi, Bazrafshan, Edris, Esrafili, Ali, Yang, Jae-Kyu, Shirzad-Siboni, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407879/
https://www.ncbi.nlm.nih.gov/pubmed/25908992
http://dx.doi.org/10.1186/s40201-015-0194-y
_version_ 1782367975559397376
author Farzadkia, Mahdi
Bazrafshan, Edris
Esrafili, Ali
Yang, Jae-Kyu
Shirzad-Siboni, Mehdi
author_facet Farzadkia, Mahdi
Bazrafshan, Edris
Esrafili, Ali
Yang, Jae-Kyu
Shirzad-Siboni, Mehdi
author_sort Farzadkia, Mahdi
collection PubMed
description Metronidazole (MNZ) is a brand of nitroimidazole antibiotic, which is generally used in clinical applications and extensively used for the treatment of infectious diseases caused by anaerobic bacteria and protozoans. The aim of this investigation was to degrade MNZ with illuminated TiO(2) nanoparticles at different catalyst dosage, contact time, pH, initial MNZ concentration and lamp intensity. Maximum removal of MNZ was observed at near neutral pH. Removal efficiency was decreased by increasing dosage and initial MNZ concentration. The reaction rate constant (k(obs)) was decreased from 0.0513 to 0.0072 min(−1) and the value of electrical energy per order (E(Eo)) was increased from 93.57 to 666.67 (kWh/m(3)) with increasing initial MNZ concentration from 40 to 120 mg/L, respectively. The biodegradability estimated from the BOD5/COD ratio was increased from 0 to 0.098. The photocatalyst demonstrated proper photocatalytic activity even after five successive cycles. Finally, UV/TiO(2) is identified as a promising technique for the removal of antibiotic with high efficiency in a relatively short reaction time.
format Online
Article
Text
id pubmed-4407879
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44078792015-04-24 Photocatalytic degradation of Metronidazole with illuminated TiO(2) nanoparticles Farzadkia, Mahdi Bazrafshan, Edris Esrafili, Ali Yang, Jae-Kyu Shirzad-Siboni, Mehdi J Environ Health Sci Eng Research Article Metronidazole (MNZ) is a brand of nitroimidazole antibiotic, which is generally used in clinical applications and extensively used for the treatment of infectious diseases caused by anaerobic bacteria and protozoans. The aim of this investigation was to degrade MNZ with illuminated TiO(2) nanoparticles at different catalyst dosage, contact time, pH, initial MNZ concentration and lamp intensity. Maximum removal of MNZ was observed at near neutral pH. Removal efficiency was decreased by increasing dosage and initial MNZ concentration. The reaction rate constant (k(obs)) was decreased from 0.0513 to 0.0072 min(−1) and the value of electrical energy per order (E(Eo)) was increased from 93.57 to 666.67 (kWh/m(3)) with increasing initial MNZ concentration from 40 to 120 mg/L, respectively. The biodegradability estimated from the BOD5/COD ratio was increased from 0 to 0.098. The photocatalyst demonstrated proper photocatalytic activity even after five successive cycles. Finally, UV/TiO(2) is identified as a promising technique for the removal of antibiotic with high efficiency in a relatively short reaction time. BioMed Central 2015-04-21 /pmc/articles/PMC4407879/ /pubmed/25908992 http://dx.doi.org/10.1186/s40201-015-0194-y Text en © Farzadkia et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Farzadkia, Mahdi
Bazrafshan, Edris
Esrafili, Ali
Yang, Jae-Kyu
Shirzad-Siboni, Mehdi
Photocatalytic degradation of Metronidazole with illuminated TiO(2) nanoparticles
title Photocatalytic degradation of Metronidazole with illuminated TiO(2) nanoparticles
title_full Photocatalytic degradation of Metronidazole with illuminated TiO(2) nanoparticles
title_fullStr Photocatalytic degradation of Metronidazole with illuminated TiO(2) nanoparticles
title_full_unstemmed Photocatalytic degradation of Metronidazole with illuminated TiO(2) nanoparticles
title_short Photocatalytic degradation of Metronidazole with illuminated TiO(2) nanoparticles
title_sort photocatalytic degradation of metronidazole with illuminated tio(2) nanoparticles
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407879/
https://www.ncbi.nlm.nih.gov/pubmed/25908992
http://dx.doi.org/10.1186/s40201-015-0194-y
work_keys_str_mv AT farzadkiamahdi photocatalyticdegradationofmetronidazolewithilluminatedtio2nanoparticles
AT bazrafshanedris photocatalyticdegradationofmetronidazolewithilluminatedtio2nanoparticles
AT esrafiliali photocatalyticdegradationofmetronidazolewithilluminatedtio2nanoparticles
AT yangjaekyu photocatalyticdegradationofmetronidazolewithilluminatedtio2nanoparticles
AT shirzadsibonimehdi photocatalyticdegradationofmetronidazolewithilluminatedtio2nanoparticles